{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:18:31Z","timestamp":1769555911173,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"DOI":"10.7759\/cureus.102373","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:28:14Z","timestamp":1769509694000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis"],"prefix":"10.7759","author":[{"given":"Taro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinatsu","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101841","article-title":"Lupus nephritis in children: novel perspectives","volume":"59","author":"Pennesi M","year":"2023","unstructured":"Pennesi M, Benvenuto S. Lupus nephritis in children: novel perspectives. Medicina (Kaunas). 2023, 59:1841. 10.3390\/medicina59101841","journal-title":"Medicina (Kaunas)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04686-1","article-title":"Kidney outcomes for children with lupus nephritis","volume":"36","author":"Oni L","year":"2021","unstructured":"Oni L, Wright RD, Marks S, Beresford MW, Tullus K. Kidney outcomes for children with lupus nephritis. Pediatr Nephrol. 2021, 36:1377-85. 10.1007\/s00467-020-04686-1","journal-title":"Pediatr Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2017.17088","article-title":"Therapeutic plasma exchange for refractory SLE: a comparison of outcomes between different sub-phenotypes","volume":"5","author":"Soyu\u00f6z A","year":"2018","unstructured":"Soyu\u00f6z A, Karada\u011f \u00d6, Karaa\u011fa\u00e7 T, K\u0131l\u0131\u00e7 L, Bilgen \u015eA, \u00d6zcebe O\u0130. Therapeutic plasma exchange for refractory SLE: a comparison of outcomes between different sub-phenotypes. Eur J Rheumatol. 2018, 5:32-6. 10.5152\/eurjrheum.2017.17088","journal-title":"Eur J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2023.103675","article-title":"Basic principles of therapeutic plasma exchange","volume":"62","author":"Weinstein R","year":"2023","unstructured":"Weinstein R. Basic principles of therapeutic plasma exchange. Transfus Apher Sci. 2023, 62:103675. 10.1016\/j.transci.2023.103675","journal-title":"Transfus Apher Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis","volume":"105","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Kidney Int. 2024, 105.S1-S69. 10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5414\/cnp57108","article-title":"Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative lupus nephritis","volume":"57","author":"Nakamura T","year":"2002","unstructured":"Nakamura T, Ushiyama C, Hara M, et al.. Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative lupus nephritis. Clin Nephrol. 2002, 57:108-13. 10.5414\/cnp57108","journal-title":"Clin Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-1101(1998)13:4<163::aid-jca4>3.0.co;2-1","article-title":"Randomized controlled trial of pulse\/synchronization cyclophosphamide\/apheresis for proliferative lupus nephritis","volume":"13","author":"Wallace DJ","year":"1998","unstructured":"Wallace DJ, Goldfinger D, Pepkowitz SH, Fichman M, Metzger AL, Schroeder JO, Euler HH. Randomized controlled trial of pulse\/synchronization cyclophosphamide\/apheresis for proliferative lupus nephritis. J Clin Apher. 1998, 13:163-6. 10.1002\/(sici)1098-1101(1998)13:4&lt;163::aid-jca4&gt;3.0.co;2-1","journal-title":"J Clin Apher"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262101","article-title":"A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group","volume":"326","author":"Lewis EJ","year":"1992","unstructured":"Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med. 1992, 326:1373-9. 10.1056\/NEJM199205213262101","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxad069","article-title":"A successful plasma exchange in\u00a0bridging to rituximab for\u00a0severe neuropsychiatric lupus and\u00a0lupus nephritis with viral infections and\u00a0aspiration pneumonia","volume":"8","author":"Kagitani M","year":"2024","unstructured":"Kagitani M, Fujiki Y, Suzuka T, Ooe K, Sakamoto A, Takeuchi T, Azuma H. A successful plasma exchange in\u00a0bridging to rituximab for\u00a0severe neuropsychiatric lupus and\u00a0lupus nephritis with viral infections and\u00a0aspiration pneumonia. Mod Rheumatol Case Rep. 2024, 8:276-9. 10.1093\/mrcr\/rxad069","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref10","article-title":"[A case of refractory childhood-onset LN treated with multi-target therapy, hydroxychloroquine, immuno-adsorption plasmapheresis and rituximab]","volume":"9","author":"Takagi Y","year":"2018","unstructured":"Takagi Y, Yasuko Kobayashi, Yuka Ikeuchi, et al.. [A case of refractory childhood-onset LN treated with multi-target therapy, hydroxychloroquine, immuno-adsorption plasmapheresis and rituximab]. J Clin Pediatr Rheumatol. 2018, 9:45-50.","journal-title":"J Clin Pediatr Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020444","article-title":"Clinical use and molecular action of corticosteroids in the pediatric age","volume":"20","author":"Ferrara G","year":"2019","unstructured":"Ferrara G, Petrillo MG, Giani T, et al.. Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci. 2019, 20:444. 10.3390\/ijms20020444","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2178297","article-title":"Belimumab for the treatment of pediatric patients with lupus nephritis","volume":"23","author":"Stohl W","year":"2023","unstructured":"Stohl W, Kwok A. Belimumab for the treatment of pediatric patients with lupus nephritis. Expert Opin Biol Ther. 2023, 23:243-51. 10.1080\/14712598.2023.2178297","journal-title":"Expert Opin Biol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05662-9","article-title":"Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis","volume":"183","author":"Li H","year":"2024","unstructured":"Li H, Chen C, Yang H, Tu J. Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis. Eur J Pediatr. 2024, 183:3987-95. 10.1007\/s00431-024-05662-9","journal-title":"Eur J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-015-0043-3","article-title":"Systemic lupus erythematosus and thrombosis","volume":"13","author":"Bazzan M","year":"2015","unstructured":"Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis. Thromb J. 2015, 13:16. 10.1186\/s12959-015-0043-3","journal-title":"Thromb J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/428269","article-title":"Thrombosis in systemic lupus erythematosus: a review article","volume":"2012","author":"Al-Homood IA","year":"2012","unstructured":"Al-Homood IA. Thrombosis in systemic lupus erythematosus: a review article. ISRN Rheumatol. 2012, 2012:428269. 10.5402\/2012\/428269","journal-title":"ISRN Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456077-successful-bridging-to-rituximab-with-plasma-exchange-in-a-pediatric-patient-with-severe-lupus-nephritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:28:14Z","timestamp":1769509694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456077-successful-bridging-to-rituximab-with-plasma-exchange-in-a-pediatric-patient-with-severe-lupus-nephritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.102373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}